A detailed history of Gps Wealth Strategies Group, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Gps Wealth Strategies Group, LLC holds 119 shares of IONS stock, worth $4,576. This represents 0.0% of its overall portfolio holdings.

Number of Shares
119
Previous 119 -0.0%
Holding current value
$4,576
Previous $5,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$36.45 - $47.7 $2,369 - $3,100
-65 Reduced 35.33%
119 $5,000
Q1 2024

Apr 30, 2024

SELL
$42.03 - $53.55 $588 - $749
-14 Reduced 7.07%
184 $7,000
Q3 2023

Oct 25, 2023

BUY
$38.5 - $47.13 $539 - $659
14 Added 7.61%
198 $8,000
Q2 2023

Jul 17, 2023

BUY
$34.73 - $43.33 $2,257 - $2,816
65 Added 54.62%
184 $7,000
Q1 2023

Apr 17, 2023

BUY
$33.58 - $41.2 $3,996 - $4,902
119 New
119 $4,000
Q1 2021

Apr 15, 2021

BUY
$42.51 - $63.78 $5,058 - $7,589
119 New
119 $5,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.46B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Gps Wealth Strategies Group, LLC Portfolio

Follow Gps Wealth Strategies Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gps Wealth Strategies Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gps Wealth Strategies Group, LLC with notifications on news.